AFRM vs DMAC
Affirm Holdings Inc (AFRM) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
DMAC does not have a complete income-statement cache yet.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the AFRM and DMAC stock pages for the full models.
Not investment advice.